The Li-Fraumeni syndrome is caused by a heterozygous mutation in TP53 and is typically characterized by soft tissue and bone sarcomas, breast cancers, central nervous system tumors, leukemia, and adrenal tumors. This evidence concerns the gene TP53 and Li-Fraumeni syndrome.